Zobrazeno 1 - 10
of 370
pro vyhledávání: '"Jeffrey B Geske"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nasibeh Zanjirani Farahani, PhD, Mateo Alzate Aguirre, MD, Vanessa Karlinski Vizentin, MD, Moein Enayati, PhD, J. Martijn Bos, MD, PhD, Andredi Pumarejo Medina, MD, Kathryn F. Larson, MD, Kalyan S. Pasupathy, PhD, Christopher G. Scott, MS, April L. Zacher, MS, Eduard Schlechtinger, MS, Bruce K. Daniels, RDCS, Vinod C. Kaggal, MS, Jeffrey B. Geske, MD, Patricia A. Pellikka, MD, Jae K. Oh, MD, Steve R. Ommen, MD, Garvan C. Kane, MD, Michael J. Ackerman, MD, PhD, Adelaide M. Arruda-Olson, MD, PhD
Publikováno v:
Mayo Clinic Proceedings: Digital Health, Vol 2, Iss 4, Pp 564-573 (2024)
Objective: To develop machine learning tools for automated hypertrophic cardiomyopathy (HCM) case recognition from echocardiographic metrics, aiming to identify HCM from standard echocardiographic data with high performance. Patients and Methods: Fou
Externí odkaz:
https://doaj.org/article/6ddece60adbe4ec0872121c1ca8a7c1c
Autor:
Tedy Sawma, MD, Hartzell V. Schaff, MD, Jeffrey B. Geske, MD, Joseph A. Dearani, MD, Steve R. Ommen, MD
Publikováno v:
JTCVS Open, Vol 20, Iss , Pp 29-36 (2024)
Background: Patients with hypertrophic cardiomyopathy (HCM) are at increased risk of developing cardiac arrhythmias and have a high prevalence of cardiac implantable electronic device (CIED) use. Tricuspid regurgitation (TR) is a potential complicati
Externí odkaz:
https://doaj.org/article/674f37a7a989445f80b98f587144968e
Autor:
Jeffrey B. Geske
Publikováno v:
European Heart Journal. 42:3119-3119
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7e108ae9ab58eb25381e46447cb8c6c
https://doi.org/10.1093/eurheartj/ehab142
https://doi.org/10.1093/eurheartj/ehab142
Autor:
Awais A. Malik, Ushasi Saraswati, William R. Miranda, Megan Covington, Christopher G. Scott, Alex T. Lee, Adelaide Arruda‐Olson, Jeffrey B. Geske, Kyle W. Klarich, Vidhu Anand
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 9 (2024)
Background Symptomatic limitations in apical hypertrophic cardiomyopathy may occur because of diastolic dysfunction with resultant elevated left ventricular filling pressures, cardiac output limitation to exercise, pulmonary hypertension (PH), valvul
Externí odkaz:
https://doaj.org/article/9411a9364f4a43de9332cd5e631e7d07
Autor:
Mohamad S. Alabdaljabar, Mohamed Elhadi, Jeffrey B. Geske, Kyle W. Klarich, Mayra Guerrero, Mackram F. Eleid
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 9 (2024)
Background Previous studies have shown that women with hypertrophic obstructive cardiomyopathy (HCM) have worse long‐term outcomes irrespective of intervention. However, the outcomes of patients undergoing alcohol septal ablation (ASA) based on sex
Externí odkaz:
https://doaj.org/article/efc93e7f1602421cb157dcf8f5612479
Autor:
John P. Bois, MD, Chadi Ayoub, MBBS, PhD, Jeffrey B. Geske, MD, Yee Weng Wong, MBBS, MHS, Muhannad A. Abbasi, MBBCh, Thomas A. Foley, MD, Sharon L. Mulvagh, MD, Christopher G. Scott, MS, Steve R. Ommen, MD, Patricia A. Pellikka, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 7, Iss 4, Pp 309-319 (2023)
Objectives: To determine whether ultrasound enhancing agent (UEA) changes maximal wall thickness (WT) in hypertrophic cardiomyopathy (HCM), and if it improves correlation with magnetic resonance imaging (MRI). Patients and Methods: A total of 107 pat
Externí odkaz:
https://doaj.org/article/0f0250f806994eaa8f739aab0b4018b2
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 1919-1927 (2023)
Abstract Aims Data on the clinical course of hypertrophic cardiomyopathy (HCM) are mainly derived from tertiary HCM centre studies, and knowledge of clinical outcomes of patients leaving specialty care and returning to local physicians is limited due
Externí odkaz:
https://doaj.org/article/472bc24915da418381cb4cd5663fc42b
Autor:
Vidhu Anand, Megan K. Covington, Ushasi Saraswati, Christopher G. Scott, Alexander T. Lee, Robert P. Frantz, Nandan S. Anavekar, Jeffrey B. Geske, Adelaide M. Arruda-Olson, Kyle W. Klarich
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2024)
IntroductionApical hypertrophic cardiomyopathy (ApHCM) is a subtype of hypertrophic cardiomyopathy (HCM) that affects up to 25% of Asian patients and is not as well understood in non-Asian patients. Although ApHCM has been considered a more “benign
Externí odkaz:
https://doaj.org/article/e16aff4668c5466b877c1e68faaf9cff
Autor:
Daokun Sun, MD, MPH, Hartzell V. Schaff, MD, Rick A. Nishimura, MD, Jeffrey B. Geske, MD, Joseph A. Dearani, MD, Steve R. Ommen, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 7, Iss 1, Pp 45-50 (2023)
Objective: To investigate the in-hospital outcomes of acute ischemic stroke in patients with hypertrophic cardiomyopathy (HCM). Patients and Methods: Using weighted discharge data from the National Inpatient Sample, we identified 5804 nonelective hos
Externí odkaz:
https://doaj.org/article/4e581a38d4814078a85ba0b02e16d3e6